COST
48
-2
EMC
60
-12
WDC
68
-6
NVDA
47
-5
PNW
60
-4
PFE
39
-2
AIV
41
-2
VIX
25
3
SWK
61
-3
GE
72
5
NDAQ
73
-2
IRM
46
-11
MCHP
49
-5
GOOGL
59
9
PVH
44
-4
QCOM
44
-5
URI
46
-4
REGN
57
-2
FCX
74
-2
MAS
60
-2
COST
48
-2
EMC
60
-12
WDC
68
-6
NVDA
47
-5
PNW
60
-4
PFE
39
-2
AIV
41
-2
VIX
25
3
SWK
61
-3
GE
72
5
NDAQ
73
-2
IRM
46
-11
MCHP
49
-5
GOOGL
59
9
PVH
44
-4
QCOM
44
-5
URI
46
-4
REGN
57
-2
FCX
74
-2
MAS
60
-2
Financhill
Back

Impala Platinum Holdings Ltd. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
68

IMPUY
Impala Platinum Holdings Ltd.

Last Price:
$13.62
Seasonality Move:
9.95%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.68
Seasonality Move:
11.58%
Buy
68
Impala Platinum Holdings Ltd. (IMPUY) is a Buy

Is Impala Platinum Holdings Ltd. a Buy, Sell or Hold?

  • The current Impala Platinum Holdings Ltd. [IMPUY] share price is $13.46. The Score for IMPUY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • IMPUY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IMPUY Stock Price Chart

What is Impala Platinum Holdings Ltd.'s stock price today?

  • The Impala Platinum Holdings Ltd. share price today is $13.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMPUY is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

IMPUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.5 Buy
Relative Strength Index (14 RSI): 67.27 Buy
Chaikin Money Flow: -160268 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.04 - 12.8) Buy
Bollinger Bands (100): (9.82 - 12.42) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

IMPUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.94 Buy
20-day SMA: 12.08 Buy
50-day SMA: 11.89 Buy
200-day SMA: 9.19 Buy
8-day EMA: 12.94 Buy
20-day EMA: 12.37 Buy
50-day EMA: 11.81 Buy
200-day EMA: 9.69 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Impala Platinum Holdings Ltd. Earnings Growth & IMPUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Impala Platinum Holdings Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):